HOME >> BIOLOGY >> NEWS
Copper may play role in 'starving' cancer to standstill

COLLEGE STATION -- Starving a cancerous tumor of its blood supply might stop its growth while other treatments aim to kill it.

"Nutrient depletion" is how Dr. Ed Harris, Texas A&M University biochemist, describes the process in the February issue of Nutrition Reviews. His article traces how independent studies around the world led researchers to consider copper, a trace mineral in the human diet, for its potential in controlling cancerous growth.

"The idea is to deprive a selective nutrient from being active in tumors. In research so far, there is no indication of anyone being cured, but tumors have stopped growing," said Harris, who is an expert on the relation of copper in various human diseases. "Ultimately, nutrient depletion may be used in combination with other treatments."

The role of copper to control cancer traces its beginnings to Dr. Judah Folkman of the Harvard School of Medicine, whose pioneering work in angiogenesis, or the formation of new blood cells, began about 40 years ago but only since the 1980s have been recognized in medical research. Folkman first launched the idea that if a tumor is to grow, it must have its own blood supply, Harris said.

"For one increment of tumor growth, Folkman said, there also must be one increment of capillary or vessel growth," Harris noted. "And that was shocking."

But that astonishing notion led some researchers to explore ways to stop the capillary growth that nourished tumors. About the same time, other researchers were examining the role of copper in forming blood vessels.

To test a theory of whether copper was instrumental in blood vessel formation, scientists needed an organ that had none. They found that in the cornea of rabbit's eyes. Small pellets of copper were implanted into rabbit corneas, and soon vessels formed around them, the biochemist noted.

Then came the idea that if copper was needed to create blood vessels, and if blood vessels were necessary
'"/>

Contact: Kathleen Phillips
ka-phillips@tamu.edu
979-845-2872
Texas A&M University - Agricultural Communications
11-Feb-2004


Page: 1 2

Related biology news :

1. Copper chelation is a promising new therapy for clogged arteries
2. Copper is crucial for embryonic deveopment, say U-M scientists
3. Leader in cancer treatment and prevention research honored
4. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
5. Chemical derived from vitamin-E shows early promise as cancer drug
6. New molecular link key to cellular proteins involved in cancer progression, other diseases
7. Phase II trials of second-generation antisense cancer drug planned following successful early study
8. Trial shows which brain cancer patients benefit from temozolomide
9. Genetic differences might help distinguish thyroid cancers
10. Evidence builds for potential new cancer drug target
11. New sequence involved in DNA replication timing may aid in cancer detection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... GENOA, Italy , May 23, 2017  Hunova, the first robotic ... and trunk, has been officially launched in Genoa, Italy ... Europe and the USA . The ... launched on the market by the IIT spin-off Movendo Technology thanks to ... view the Multimedia News Release, please click: ...
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
(Date:4/18/2017)... , April 18, 2017  Socionext Inc., a global expert in ... media edge server, the M820, which features the company,s hybrid codec ... provided by Tera Probe, Inc., will be showcased during the upcoming ... NAB show at the Las Vegas Convention ... Click ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... today it will be hosting a Webinar titled, “Pathology is going digital. Is ... , on digital pathology adoption best practices and how Proscia improves lab economics ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/9/2017)... ... 2017 , ... The award-winning American Farmer television series will feature 3 Bar ... Tuesdays at 8:30aET on RFD-TV. , With global population estimates nearing ten billion ... continue to feed a growing nation. At the same time, many of our valuable ...
Breaking Biology Technology:
Cached News: